Quanta Pharma 5-Amino-1mq

Quanta Pharma 5-Amino-1MQ Research Benefits

• NNMT inhibition: Selectively blocks nicotinamide N-methyltransferase, the enzyme responsible for degrading NAD+ precursors and SAM methyl donors
• Reduced adipogenesis: Preclinical research demonstrates significant reduction in fat cell formation and white adipose tissue accumulation
• NAD+ preservation: By inhibiting NNMT, cellular nicotinamide is conserved and available for NAD+ synthesis, supporting mitochondrial function
• Metabolic regulation: Investigated for effects on insulin sensitivity, glucose metabolism, and cellular energy expenditure
• Anti-obesity research: Studies in diet-induced obesity models have shown reductions in body weight and adipose mass without affecting food intake
• Orally bioavailable: As a small molecule rather than a peptide, it maintains activity via oral administration in research protocols, avoiding the need for injection

How Quanta Pharma 5-Amino-1MQ Works

5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) is a small molecule selective inhibitor of nicotinamide N-methyltransferase, or NNMT. NNMT is an enzyme expressed at particularly high levels in adipose tissue and the liver, where its role is to transfer a methyl group from S-adenosylmethionine (SAM) onto nicotinamide, producing 1-methylnicotinamide as a waste product. This process depletes both the methyl donor pool and the body’s reserve of nicotinamide, the direct precursor to NAD+.

By inhibiting NNMT, Quanta Pharma 5-Amino-1MQ preserves both of these critical metabolic substrates. Research in diet-induced obese mouse models has shown that selective NNMT inhibition reduces fat mass, lowers adipocyte size, and improves insulin sensitivity, without suppressing appetite or caloric intake. The compound appears to work primarily by preventing the metabolic “drain” that NNMT imposes on adipose tissue, allowing fat cells to burn energy more efficiently.

Additionally, Quanta Pharma 5-Amino-1MQ has drawn significant interest in longevity research, given the central role NAD+ plays in sirtuin activity, mitochondrial biogenesis, and DNA repair. Its small molecule structure makes it a practical orally-administered research tool, setting it apart from the injectable peptides that dominate this research space.

Quanta Pharma 5-Amino-1MQ vs Traditional NAD+ Precursors

While NAD+ precursors like NMN and NR aim to raise NAD+ levels by supplying more raw material, 5-Amino-1MQ takes the opposite approach: it prevents NAD+ precursors from being destroyed in the first place. This makes Quanta Pharma 5-Amino-1MQ a mechanistically distinct research tool, particularly suited to studies focused on adipose tissue metabolism, where NNMT expression is highest. Researchers studying obesity, metabolic syndrome, or adipocyte biology often prefer NNMT inhibition over simple precursor supplementation because the effect is concentrated where it matters most.

Why Choose Quanta Pharma 5-Amino-1MQ?

Quanta Pharma is renowned for producing pharmaceutical-grade research compounds with exceptional purity and accurate dosing. The 50mg vial of Quanta Pharma 5-Amino-1MQ has been independently verified by Analiza Białek, one of Europe’s most respected analytical laboratories, with confirmed content of 52.53mg against a 50mg label claim and 99% purity on the finished product. Combined with pharmaceutical-grade production, precise fill accuracy, and UK-based stock for fast dispatch, it is the confident choice for serious researchers working in metabolic and longevity studies.